MYOZYME
As listed in the register: MYOZYME 50 mg, poudre pour solution à diluer pour perfusion
50 mg · poudre pour solution à diluer pour perfusion
- Prescription only
- Active substance
- Alglucosidase Alfa
- Made by
- SANOFI (PAYS-BAS)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
European UnionNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | SANOFI (PAYS-BAS) |
|---|---|
| Active substance | Alglucosidase Alfa |
| Strength | 50 mg |
| Form | poudre pour solution à diluer pour perfusion |
| Route | intraveineuse |
| Dispensing (as stated by the register) | prescription hospitalière · liste I · les six premières administrations doivent être effectuées en milieu hospitalier |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/06/333 |
| Name in the register | MYOZYME 50 mg, poudre pour solution à diluer pour perfusion |
| Packs | 1 flacon(s) en verre de 20 ml · 10 flacon(s) en verre de 20 ml · 1 flacon(s) en verre ( abrogée le 09/01/2023) · 10 flacon(s) en verre ( abrogée le 09/01/2023) |
| CIS | 61065137 |
| CIP13 | 3400930247006 |
| CIP13 | 3400930247013 |
| CIP13 | 3400956957514 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).